ベータ
治験レーダーAI
治験 NCT04848038 (COMET)(対象:健康な老化)は実施中/登録終了です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。
フィルター基準に一致する試験が1件見つかりました
タイル表示

Combined Exercise Trial (COMET)

実施中/登録終了
治験(臨床試験)の詳細は主に英語で提供されています。しかし、治験レーダーAIが支援できます!「治験を説明」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT04848038 (COMET) は 介入研究 臨床試験 で、健康な老化 に関するものです。現在は 実施中/登録終了 で、2021年10月14日 から開始しています。280 名の参加者 の募集が計画されています。この治験は カンザス大学 によって主催され、2026年7月31日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2025年5月25日 です。
概要
The number of older Americans will double in the next 4 decades to nearly 90 million, placing an unprecedented financial and resource burden on the health care system. Exercise has clear and demonstrable physical benefits, but a more precise understanding of how exercise supports cognitive function is essential. Demonstrating definitively that exercise as recommended by public health entities has benefits for cognition would have enormous public health implications, encourage the public to adapt more active lifestyles, and stimulate the development of effective exercise delivery programs.
詳細説明
Older adults often experience physical decline that can be directly ameliorated by physical activity and exercise. Evidence is building that exercise prevents cognitive decline or delays the onset of debilitating dementia (e.g. Alzheimer's disease) yet, the optimal dose and combination of exercise modalities for promoting brain health, however, remains unknown and essentially untested.

The long-term research goal of this project is to develop and test strategies to support successful aging and prevent Alzheimer's disease. The study will enroll 280 individuals, age 65 to 80 years without cognitive impairment, into a 26-week exercise intervention to test the combined and independent effects of aerobic and resistance training on cognition, brain structure, and physical function. The project will also explore underlying biological mechanisms that may link exercise with brain health.

Participants will be randomized into 1 of 4 groups: flexibility, toning and balance (control), aerobic exercise training, progressive resistance training, or combined aerobic and resistance training. All intervention groups represent the most common modalities of exercise and directly reflect the public health recommendations for aerobic and resistance training. Exercise training will occur in a community setting through the network of Greater Kansas City Young Men's Christian Association. It is hypothesized that 26 weeks of exercise will improve 1) cognitive performance, 2) regional brain volume, 3) cardiorespiratory fitness and strength 4) biomarkers.

This will be the largest study to assess the combined and independent effects of the two most recommended forms of exercise. Demonstrating specific exercise effects on cognitive function and brain health in older adults would have enormous public health implications. The study's results will also impact public health policy and education by providing evidence towards the specific or synergistic effects of aerobic and resistance training on cognition and brain structure. Encouraging the public to adapt more active lifestyles and stimulate the development of effective exercise delivery programs to enhance initiation and maintenance of physical activity interventions is key to increasing the number of quality years of life for America's aging population.

公式タイトル

Differential Effects of Exercise Modality on Cognition and Brain in Older Adults

疾患/病気
健康な老化
その他の研究識別子
  • COMET
  • 146904
NCT番号
開始日
2021-10-14
最終更新日
2025-05-25
終了予定日
2026-07-31
目標参加者数
280
試験の種類
介入研究
治験の相・段階
該当なし
状況
実施中/登録終了
主目的
基礎研究
割付方法
無作為化
介入モデル
ファクトリアル割当
盲検化
単盲検
群(アーム)/介入
参加グループ/群介入/治療法
実薬対照薬Core and Fusion Training
150 minutes/week of Core and Fusion exercise, a mix of low impact toning, strengthening, flexibility and balance exercises.
運動
Standard public health exercise recommendations
実薬対照薬Endurance Training
Moderate-intensity endurance training such as brisk walking, 150 minutes/week over 3-5 days. Progression based on a set schedule. In addition 0-2 days of Core and Fusion control exercise will also be recommended.
運動
Standard public health exercise recommendations
実薬対照薬Weight Training
Progressive resistance training 2 days/week, non-consecutive, of 2 sets (10 - 15 repetitions) of 10 exercises (\~75 minutes/week). Progression based on repetition completion and 1-repetition maximum. In addition 3 days of Core and Fusion control exercise will also be recommended.
運動
Standard public health exercise recommendations
実薬対照薬Combined Endurance and Weight Training
Moderate-intensity endurance training such as brisk walking, 150 minutes/week over 3-5 days. Progression based on a set schedule. Progressive resistance training 2 days/week, non-consecutive, of 2 sets (10 - 15 repetitions) of 10 exercises (\~75 minutes/week). Progression based on repetition completion and 1-repetition maximum.
運動
Standard public health exercise recommendations
主要評価項目
評価指標指標の説明時間枠
Global Cognition
Assessing change in cognitive function from baseline to 12 months. The 6 month measure is being used to assess the trajectory of the change. A comprehensive neuropsychological battery will be used that assesses a global cognition score derived from domains of cognition (e.g. Executive Function, Visuospatial Processing, Episodic Memory, Processing Speed). We will use a second order confirmatory factor analysis (CFA) to estimate the factor loadings between the observed indicators and the first order factors and between the first and second order factors. The CFA will use baseline data to avoid any potential intervention related biases. The primary outcome will be constructed by summing the weighted average (by the estimated first and second order loadings) of the standardized observed scores across the cognitive tests.
Baseline, 6 months, 12 months
副次評価項目
評価指標指標の説明時間枠
Hippocampal volume
Volume of bilateral hippocampus in milliliters
Baseline, 12 months
Peak oxygen consumption
Peak volume of oxygen used in in milliliters per kilogram of body mass per minute during a graded maximal exercise test
Baseline, 12 months
1-Repetition Maximum
The maximum amount of mass that can be lifted one time (summed leg press and chest press)
Baseline, 12 months
適格基準

対象年齢
高齢者
試験の最低年齢
65 Years
対象性別
全て
健康なボランティアを受け入れる
はい
  • Age 65-80 yrs (inclusive at time of consent).
  • Conversant English speaking and reading ability.
  • Medical clearance by a health care provider.
  • Reliable means of transportation.
  • Telephone Interview of Cognitive Status score > 25 and adjudication of normal cognition based on cognitive test data by a study medical monitor.

  • Intention to move out of the area or travel for more than 4 weeks in the next year.
  • Use of an assistive device for ambulation.
  • Joint pain severe enough to prevent taking walks in community, lifting objects over your head due to pain or restriction of movement, or that is worsened by increasing physical activity.
  • Any MRI contraindications or refusal to attempt MRI.
  • Treatment for alcohol or substance abuse in the last 2 years.
  • Treatment for cancer (other than non-metastatic, localized cancer) in the last 2 years.
  • Currently taking insulin.
  • Diagnosis of heart disease, heart failure, heart attack, or heart surgery or chest pain with effort in the last 2 years.
  • Untreated atrial fibrillation, valve replacements, angioplasty or stent placement in the last 2 years regardless of physician clearance.
  • History of major psychiatric illness including schizophrenia (not including general anxiety disorder or depression), multiple sclerosis, Parkinson's, Dementia, mild cognitive impairment, brain injury (traumatic or clinically evident Stroke), or similar, likely to negatively impact cognitive testing.
  • Head injury with loss of consciousness for more than a few minutes.
  • Change in blood pressure medication in the last 2 months.
  • Considered "Active" or engaging in a progressive resistance training 2 or more times a week.
  • reported condition likely to compromise ability to safely perform exercise as determined by study medical monitor (e.g. chronic obstructive pulmonary disease, Lupus, end stage renal disease, etc.)
連絡先情報がありません。
1 1カ国の場所

Kansas

University of Kansas Alzheimer's Disease Center, Fairway, Kansas, 66205, United States